Literature DB >> 15823750

BRCA2: breaks, mistakes and failed separations.

Teresa M Rudkin1, William D Foulkes.   

Abstract

BRCA2 was identified in 1995, one year after BRCA1. In terms of knowledge of the function of its product, BRCA2 has remained the less well-characterised gene. Both BRCA1 and BRCA2 are closely implicated in the repair of double-strand breaks in DNA by homologous recombination, but beyond that a function for BRCA2 has been hard to discern. A recent study has extended the function of BRCA2 to the regulation of cell cleavage and separation. Other groups have also shown how BRCA2, RAD51 and DSS1 co-exist in a ménage à trois and how the disruption of any one of the three cohabitants can have disastrous consequences for the cell.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15823750     DOI: 10.1016/j.molmed.2005.02.003

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  5 in total

Review 1.  Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour.

Authors:  R H Scott; C A Stiller; L Walker; N Rahman
Journal:  J Med Genet       Date:  2006-05-11       Impact factor: 6.318

2.  Roles of BCCIP in chromosome stability and cytokinesis.

Authors:  X Meng; J Fan; Z Shen
Journal:  Oncogene       Date:  2007-04-23       Impact factor: 9.867

Review 3.  A comprehensive analysis of BRCA2 gene: focus on mechanistic aspects of its functions, spectrum of deleterious mutations, and therapeutic strategies targeting BRCA2-deficient tumors.

Authors:  Anjali Shailani; Raman Preet Kaur; Anjana Munshi
Journal:  Med Oncol       Date:  2018-01-31       Impact factor: 3.064

Review 4.  KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer.

Authors:  Jonas Cicenas; Kotryna Kvederaviciute; Ingrida Meskinyte; Edita Meskinyte-Kausiliene; Aiste Skeberdyte; Jonas Cicenas
Journal:  Cancers (Basel)       Date:  2017-04-28       Impact factor: 6.639

5.  BRCA1 and BRCA2 germline mutation analysis in the Indonesian population.

Authors:  Dewajani Purnomosari; Gerard Pals; Artanto Wahyono; Teguh Aryandono; Tjakra W Manuaba; Samuel J Haryono; Paul J van Diest
Journal:  Breast Cancer Res Treat       Date:  2007-02-15       Impact factor: 4.872

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.